VISEN

VISEN Pharmaceuticals is an innovative biopharmaceutical company focused on the treatment of endocrine-related disorders. Dedicated to providing more patient-centered innovative therapies, VISEN aims to improve the treatment experience and outcomes for patients with endocrine conditions, helping them achieve a better quality of life. Prioritizing patient needs, VISEN strives to deliver first-in-class or best-in-class products and treatment solutions for endocrine diseases. Its therapeutic areas include adult endocrinology, pediatric endocrinology, and rare endocrine disorders. VISEN continuously gathers senior professionals with international backgrounds, as well as cutting-edge technologies and resources from around the world, to deepen its presence in the Chinese market. Offices have been established in Shanghai, Beijing, Hong Kong, and Taipei, with a research and manufacturing base for Greater China located in Suzhou. This enables a full-chain layout in the field of innovative endocrine drugs, from research and development to production and sales, allowing more Chinese patients with endocrine disorders to benefit earlier from advanced and reliable global treatment options.